FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
Studies suggest that DSIP works by helping the brain regulate its natural sleep rhythms and hormone balance, making it a promising peptide for overall rest, resilience, and well-being 1-4
Without Choline, fats can become trapped in the liver, where they block normal metabolic functions
Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells